Clinicians advised to wait for more data before using 2-drug HIV therapy in inexperienced patients.

Randomized controlled trial among patients unable to walk independently.

CPME believes healthcare professionals could contribute to a number of the activities involved.

The latest guidance includes seven updated and seven new recommendations.

Pathogen-driven mechanisms of cardiac injury could be the target for future therapeutic intervention to reduce cardiac complications and improve outcomes of pneumonia.

Socioeconomic disparities in the prevalence of consumption and household expenditure on potentially unhealthy products

Dual-based atazanavir/ritonavir regimen offers superior alternative for virologically suppressed adults with HIV.

Hydroxychloroquine appears to have a protective effect.

Many Muslims are expected to perform a pilgrimage to Mecca during Ramadam.

Doctors should be alert to influenza symptoms in patients who have travelled from China with the previous 10 days.

Findings do not support HPV vaccination of HIV-infected adults age 27 or older.

FT819 offers hope for a safe, mass-produced product that can broaden patient accessibility.

Vaccination is encouraged for those not able to show proof of complete vaccination or history of previous infection.

Epidemiological data and information on upstream risk factors suggest the burden of liver disease across Europe is likely to increase in future years.